H1 2024 Bispecific Landscape Review

Welcome to the H1 2024 Bispecific Landscape Review, your essential resource for understanding the latest developments in bispecific therapeutics. In the first half of 2024 alone, we’ve seen the initiation of 251 clinical trials and the approval of two groundbreaking drugs, marking a continued surge in innovation despite a strategic shift toward repurposing existing molecules. This review offers in-depth insights into these trends, plus analysis of the new bispecific assets added to Beacon, reflecting an 18% growth in the space.

Whether you’re focused on drug development, trial strategies, or investment opportunities, this review provides the critical data you need to navigate the bispecific landscape.

The Drug Landscape

Download Here

The Trial Landscape & Regulatory Announcements

Coming Soon

The Commercial Landscape & Future of Bispecifics

Coming Soon

What does the Landscape Review cover?

The Drug Landscape – Explore all of the new, approved, and discontinued bispecific assets from H1 2024.
The Trial Landscape & Regulatory Announcements – Dive into the surge in number of bispecific trials over the last 4 years, identify top disease indications, and view a list of completed trials and the latest regulatory updates.
The Commercial Landscape & Future of Bispecifics – Unlock exclusive insights into the top deals and leading companies of H1 2024, along with a preview of key assets to look out for in the second half of the year.

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.

With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.

Discover more about Beacon